Other,increases
Type,edition
Other,Targeting
Considerable,significantIncrease
Other,tangshanPeople
Other,Using
Other,dcisDiagnosis
Other,HADS
Young,femalePatient
Chinese,chinesePublic
Other,breast
16,15Percecnt
Post,directEffects
Pathologic,pathologicalSpecimen
Odds,odds
Biopsy,tissueBiopsy
Complex,sialicAcidExpression
Testing,cancerResearch
Other,fiveYearRfsrate
Other,figures
Prior,priorMedicalHistory
Subgroup,wordCloud
Other,shapes
Radiotherapy,neoadjuvantChemotherapyGroups
Actual,currentMeans
Focus,prospectiveNestedCase-controlStudy
Learning,deepLearning
Other,lungChanges
Testing,microarrayAnalysis
VAP-1,vap-1NegativeStaining
Distance,firstDiagnosis
Other,Wilm
Other,methylationStatus
Subset,group1
Other,specificGroups
Other,diagnosticUncertainty
Other,results
Other,analyses
SNVs,sharedSnvs
Hereditary,distinctiveGeneticModifications
Predictors,traditionalPredictors
Adulthood,35-64Years
Interference,assessment
Capillaries,capillaries
Other,erEvaluation
Validation,Validation
Interference,discovery
Long-term,theirLong-termSurvival
Other,those
Other,dysregulation
Testing,search
Other,targetingFxyd3-mediatedPathway
Biocharacter,agonistic/antagonisticBiocharacter
Other,Resurgery
Isolation,binaryLogisticRegressionModels
Aptamer,ssdnaAptamerMf3
Other,percecnt
Provider,humanEpidermalGrowthFactorReceptor2ReceptorStatus
PA,paTreatment
Other,kinds
Other,Applications
AMD3100,AMD3100
Other,virtualReality
Output,lisbonRegion
Hazard,risk
Restoration,careProvider
Other,symptomaticWomen
Technique,imagingTechnique
Interference,interference
Hybrid,mutationRatio
Learning,transferLearning
Presentations,rarePresentations
Other,recentDevelopments
Other,mastectomizedWomen
Focus,muchFocus
Laser,carbonDioxideLaserTechnology
Other,cpgIslands
Filter,specificEralpha-targetedProbe
Other,undifferentiatedNeoplasticCells
Testing,clinicalBreastExamination
Components,components
Other,infiltrationSimilar
Nonparticipation,nonparticipation
Comparisons,comparisons
Other,variousNon-pharmacologicalAdjuvantTherapies
Mood,complexSurgeries
Ecchymosis,dscam-as1Expression
Intensity,lowClassificationAccuracies
Finding,antigenIdentification
Other,breastCancerStudies
Young,femalePatients
Other,MRI
Subgroup,subgroupVariables
TAM,TAM
Entry,colonyFormation
Spouse,familySupport
Other,commonCancerTypes
Techniques,techniques
Other,detectionofBreastCancer
Restoration,article
Nonparticipation,feasibleCtcIsolationTechniques
Techniques,severalIntelligentTechniques
Other,appropriateSequencing
Other,studies
Other,presence
Regulatory,molecularRegulatoryNetworks
Alpha,oestrogenReceptorAlpha
Advantage,tumorSizethePositivity
Mood,agreement
Other,medianTime
Actual,currentAnalysis
Levels,microrna-22ExpressionLevels
Other,tissues
Purpose,mixedMethodsDesign
Mood,complexTreatmentAlgorithms
Traumatic,traumaticNeuroma
Binding,stableDrug-carrierBinding
Other,sensor
Ecchymosis,suutaneousEcchymosis
Other,theirTissues
Other,functionalAssessments
Other,adherence
Intensity,massMedia
Other,rnaKnockdown
Other,futureClinicalStudies
Other,repair
Contribution,coverage
DNA,dnaMethylation
Restoration,goodTolerabilitytheApatinib
Other,icgFluorescenceMethod
Other,program
Monte,monteCarloFeatureSelection-basedFeatureSelection-basedComputationalMethod
Testing,comprehensiveResearchData
Signatures,signatures
Other,conditions
Other,Mechanisms
Hazard,breastCancerRisk
BPE,BPE
Other,racialDisparity
Other,complexConsulting
Other,Data
Other,practitionersKnowledgeable
Food,inAssay
Nonparticipation,ctcIsolationTechniques
Immunohistochemistry,erImmunohistochemistry
Fibroblasts,fibroblastsAdjacent
16,22Deaths
Other,risks
Other,147Patients
RNAs,RNAs
CLB-Pt-CLB,CLB-Pt-CLB
Other,advancedStage
Ecchymosis,proteinExpression
Detection,materialDetection
Other,promoterMethylationStatus
Other,extensiveExploration
Distance,boneDensity
Other,novelty
Other,occurrence
Other,surgery
Cell,Cell
Other,interview
Purpose,contraceptiveUse
Testing,screeningPrograms
MAb,mab1e3
Various,variousMethods
Testing,nondestructiveTesting
Danger,ddtExposure
Other,factor-1Scores
Radiomics,subsequentRadiomics
Other,literature
Other,tissueDiagnosis
Alpha,eConcentration
MABA,mabaSurgery
Other,commonComplaint
Amplification,inclusion
Caregiver,membraneTypeMr
Evolve,age
Other,dissection
Comparisons,cytohistologicalComparisons
Other,NAC
Circulating,circulatingSolubleRankl
Other,therapies
Reporter,reporterAssays
Somatic,historyPhysicalExamFindings
Other,Cryopreservation
Locoregional,locoregionalRadiotherapy
Ovarian,ovarianCancer
Finding,identification
Strategy,short-termStrategy
Hybrid,mutationEvents
Restoration,material
Other,Survival
Subtype,subtype
Hazard,riskFactors
Other,premenopausalPatients
Other,smallerMyeloperoxidase
Number,hospitalCohort
Base,basis
Food,specificFoodRecommendations
Cutoff,cutoff
Regimens,shorterRadiotherapyRegimens
Number,number
Danger,nsaidExposure
Other,andfemales
Nanocarrier,nanocarrier
Other,backgroundTrastuzumab
Other,histopathologicalreports
Other,its
Other,breastCancerCases
Other,otherInotherTertiaryCentres
Other,manyBreastCancerPatients
Systematic,age-matchedSystematicRandom-samplingMethod
Other,ET
Values,cutoffValues
Percent,survivalRate
Other,diagnosis
Other,associations
Fibroblasts,cancerAssociatedFibroblasts
US,usExaminations
Neuromas,breastNeuromas
Proportion,neutrophil-to-lymphocyteRatio
Other,stagingSystems
Other,menopausalHormoneTherapy
Other,breastCancerMetastasis
Other,scope
Other,measures
Other,furtherTissue
Young,65-year-oldFemale
Other,performed
Image,image
Variants,variants
Other,Probes
Other,700
Evolve,otherAgeGroups
Other,accumulatingResults
Description,multiresolutionResult
Other,ourBreastCancerPatients
Mood,nippleAreolaComplexInvolvement
Base,molecularBasis
Actual,oxidationPeakCurrent
Danger,estrogenicExposure
RON,RON
Other,Univariate
Other,Recurrences
Other,Ki67
Necessity,immediateUnmetNeed
Factors,factors
Other,diagnosticEvaluation
Restoration,surgicalImplantationReconstruction
Will,improvedUnderstanding
Other,yearRfsrate
Other,magneticResonanceImaging
Other,she
16,100Patients
Other,Information
Mutations,Mutations
Other,epigeneticAberrations
Other,undergone
Other,408
Learning,learning
Survival,survivalRates
Signature,medianInterval
Other,we
Mutations,esr1Mutations
Baseline,baselineSt-2Level
16,25CaseReports
Co-existence,Co-existence
Evolve,medianAge
Other,twoImagingIndexes
Cross-validation,tenfoldCross-validationMatthew
10-fold,10-foldCross-validation
Other,mammograms
Other,symptoms
16,40
Signature,signature
Ecchymosis,vap-1Expression
Other,undergoing
CTC,CTC
Other,leucocytes
Other,concerns
KDM4B,scffbxo22-mediatedKdm4bDegradation
Other,molecularAnalyses
Other,measurements
Other,state-of-the-artAlgorithms
Other,cylindricalGeometries
Interference,theory-basedIntervention
Parameters,parameters
Other,Mammography
Danger,nsaidsExposure
Syndromes,syndromes
Base,advancedBreastCancerBearingMutations
Other,level
Capabilities,capabilities
Other,This
Purpose,methodsDesign
Danger,exposure
Other,their
Propagation-based,propagation-basedPhase-contrast
Positivity,accuracyScores
Other,evidence-basedRecommendations
Other,trastuzumab/pertuzumab/taxane
Other,LVI
Susceptibility,tertiarySexualHealthCenters
TBR,TBR
Other,double-maintenanceTherapy
Solicitations,multipleSolicitations
Other,SVM-BRC
Restoration,cancerCareCenter
Obstetricians,obstetricians
Accumulation,survivalData
Testing,previousCervicalCancerScreening
Other,pathologists'Awareness
Other,significance
Percent,rate
Restoration,furtherDevelopment
Other,all
Description,picture
Cohort,youngMalePatients
Predictors,predictors
Cohort,youngMen
Intensity,higherProportion
Other,twenty-twoPatients
Other,imaging
Cholecystectomy,Cholecystectomy
Contribution,contribution
16,20BreastCancerPatients
Intensity,proportion
Associations,Associations
Other,theirParaffin-embeddedTissues
Interference,multidisciplinaryAssessment
Restoration,multidisciplinaryCare
Its,itsExpressionLevel
Testing,mammographicBreastCancerScreening
Other,time
CircRNAs,massiveCircrnas
Other,molecularChanges
Other,relationship
US,usStandardization
Other,properties
Testing,fisherDiscriminantAnalysis
Caregiver,typicalWoman
Conflict,physicalActivity
Other,Belgium
MiR-511,miR-511
Other,the
Odds,speed
Other,support
Young,38-year-oldFemale
Scientific,criticalScientificBase
PFS,longerPfs
Platform,microfluidicPlatform
ERalpha,eralphaTranscription
Intensity,quality
Discovery,label-freeDetection
Other,available
Entry,appearance
Alpha,P
Number,decrease
Adulthood,0-5Years
Restoration,care
Noncoding,longNoncodingRnas
Caregiver,membraneTypeMannoseReceptor
Other,options
Testing,microscopicExamination
Will,betterUnderstanding
Other,parameterUncertainty
Antibody,paraneoplasticAntibodyPanel
Discovery,caDetection
Susceptibility,cancerSusceptibilityGenes
Number,comparisonCohort
Percent,fastRate
Purpose,aim
Coefficient,weight
Cross-validation,cross-validation
Vulnerability,vulnerability
Food,foodRecommendations
Poisson,zero-inflatedPoissonRegression
Other,1
Distinct,threeDifferentClusters
Ecchymosis,extramedullaryHaematopoiesis
Regimens,chemotherapyRegimens
Testing,moreIntensiveFollow-up
Immunohistochemical,immunohistochemicalAnalysis
Food,symptomaticHeartFailure
Accumulation,otherData
Distance,firstSteps
Intensity,emphasis
Positivity,theirAbility
Adulthood,476Years
Other,flankingCgi
Testing,patient'sMedicalHistory
MSOT,msotImaging
Asymptomatic,asymptomaticWomen
Factor,factorAnalysis
Other,omission
Other,breastMetastases
Other,902Percecnt
Other,doses
Young,malePatients
Techniques,intelligentTechniques
Other,means
Other,robustSynthesisMethods
Other,occultBreastTumors
MiRNA,mirnaExpressionProfiles
Other,third
MiR-511,mir-511Overexpression
186,186Pathology-provenS
Macrophages,tumor-associatedMacrophages
Weight,patient'sTumorBurden
Other,carbohydrateRestriction
Other,Diseases
Overexpression,Overexpression
Benchmark,therapeuticTarget
Other,delay
MiR-204-5p,miR-204-5p
Other,surgicalOutcomes
Ecchymosis,stromalExpression
Learning,separateClassificationModels
Type,description
Food,experience
Radiomics,radiomics
Cohort,fastingBlood
Cell-killing,cell-killingEffect
Purpose,long-termUse
Binding,binding
Protein-1,adhesionProtein-1
BPE,decreasedBpe
77,77
Other,tumorCells
Other,guidedImagery
Estrogen,estrogenReceptor-alpha
Guidelines,internationalGuidelines
Other,It
Distance,tumorNippleDistance
Alpha,p
Strategy,risk-stratifiedScreeningStrategy
Reverse,reverseTranscription-quantitativePolymeraseChainReaction
Other,importantPotential
Cell,cancerStemCellHypothesis
Levels,bpeLevels
Quantification,multidimensionalScaling
Other,7581StageI/iiaCases
Hazard,Risk
Antibody,murineMonoclonalAntibodies
Other,282Patients
Other,existence
Presentations,rareClinicalPresentations
Other,networks
Ecchymosis,ecchymosis
Filter,towaveletFilter
Conjugate,conjugatedEquineEstrogen
Mood,cancerControlPlanning
Lymphedema,secondaryLymphedema
Proliferation,osteopontin-750Accumulation
Other,occurringCancers
Other,8155Patients
Transcripts,Transcripts
Other,occurring
Other,resultsDiagnosed
Caregiver,70-year-oldWoman
Other,haveCenterstage
Fibroblasts,fibroblasts
TAMs,preclinicallyTams
Ecchymosis,expression
ST-2,solubleSt-2Level
Other,effectiveness
Other,exercise
Levels,expressionLevels
Testing,follow-up
Interference,complication
Mammographic,Mammographic
Cohort,elderlyPatients
Other,Cells
Distinct,differentProtocols
Focus,study'sObjectives
Other,markers
Other,large-scaleStudies
Learning,dictionaryLearning
Other,futureInterventions
Other,quadrantectomy
Testing,ourLiteratureReview
Radiotherapy,anthracyclineChemotherapyAgents
Nonparticipation,involvement
Other,clinicalDepression
SPD,spdMatrices
PFS,similarPfs
Subgroup,statisticalAssociation
Other,lesion
Summaries,knowledgeSummaries
Intensity,adjustedProportion
Other,them
Other,Residents
Testing,bioimpedanceAnalysis
Radiotherapy,radiotherapy
Allele,tumorSuppressorFunction
Other,hundreds
Other,Familiarity
Coefficient,correlationCoefficient
Other,OR
Other,recentEpigenomeStudies
Circulating,circulatingTumorCells
Spouses,Spouses
Other,caloricRestriction
Mood,controlGroup
Other,inhibited
Other,newSpecificMarkers
Considerable,considerableNumber
Subgroup,population
Will,preoperativeUnderstanding
Ecchymosis,increasedRonExpression
Other,wavelengthConsistencyIndex
Other,deep-CNN
AYAs,AYAs
Other,knockdown
Other,They
Hybrid,hybridCultures
Other,95PercecntConfidenceIntervals
Other,treatmentProcesses
Subjective,women'sPersonalGoals
Survival,theirSurvival
Testing,analysis
Cardiac,cardiacTroponins
Other,samples
Other,first-lineTreatment
Binding,drugBinding
Nondestructive,mostNondestructiveTests
Other,novelMethod
Intensity,signalIntensity
Nucleus,sox9NucleusEntry
Other,positiveChanges
Pathologic,pathologicalResults
Cohort,bloodSamples
Purpose,role
Considerable,substantialImprovements
Levels,levels
Other,suchStandardization
Neoadjuvant,neoadjuvantTreatment
SNVs,SNVs
Other,secondLargestHmo
Other,hugeVolumes
Stigmatization,mostStigmatization
Other,interpretation
Intensity,lowCtnLevels
ST-2,st-2Level
Other,noninvasiveImaging
Brain,brainMetastases
Type,localizedDescription
Reduced,decreasedRisk
Fertility,flowRate
Other,56Patients
Intensity,tumorSize
Exposure,excellentPerformance
Binding,selectiveBinding
Other,opticalAbsorptions
Restoration,rural-basedTertiaryCancerCareCenter
Other,detailedRoles
Intensity,highSensitivity
Hazard,anticipatedOutcome
Yoga,metabricTrainingSet
Other,therapy
Other,multivariate
Other,prospectiveStudies
Conflict,contrastAgents
Other,Immunohistochemistry
Symptom,effect
Oligonucleotides,rnaOligonucleotides
Focus,cohortStudy
Testing,alternativeContrast-enhancedScreeningTools
Neuroma,neuroma
Signature,three-lncrnaSignature
Result,ourPatient
Subtype,oneSpecificSubtype
Other,classifiers
Other,diagnoses
Other,most
Purpose,purpose
Hereditary,geneticChanges
CTn,cTn
Parameters,pharmacokineticParameters
Symptom,hyperglycemia
Other,Findings
Differentials,morphologicalDifferentials
Purpose,contraceptionUse
Other,framework
Other,54BreastCancerPatients
Other,sentinelNodes
Other,switch
Distinct,differentDetectionRates
Other,they
Cell,CellLines
Filter,probe
Susceptibility,healthCenters
Hazard,lowerCumulativeHazardRates
Biopsy,stereotacticWire-guidedBiopsy
Other,Isolation
Resistance,netvizzApplication
Global,firstOrganisedRound
Membrane,combinedPanel
Other,histoneModifications
MiRNAs,miRNAs
Other,insight
186,186S
Testing,comprehensiveSearch
Cox,coxProportionalHazardRegressionModels
Spouse,morcFamilyCw-typeZincFinger4Overexpression
Gene,geneExpressionLevel
Other,ourResults
Interference,drugDeliveryStrategies
Type,eighthEdition
Other,tissue
Hazard,increasedRisk
Other,resonanceImaging
Other,428BreastCancerPatients
DSCAM-AS1,DSCAM-AS1
Other,12-15Percecnt
Care,healthcareUtilization
Focus,recentDanishCohortStudy
Other,kaplan-meierCurves
Other,proposedMethod
Focus,study
Other,lymphedemaseventyPatients
Testing,unbiasedRnaSequenceAnalysis
Isolation,regressionModels
Signature,responseRate
Other,mastectomy
Yoga,yoga
Researchers,Researchers
Testing,furtherResearch
Mortality,mortalityRates
Mutations,esr1-activatingMutations
Other,outcomes
Survivors,535941Survivors
Box,transcriptionFactorForkheadBoxC1
Other,algorithm
Radiotherapy,chemotherapy
Distinct,definedSubtype
Benchmark,benchmarkMethod
RRM2,RRM2
Acupuncture,Acupuncture
Evolve,medianDiagnosisAge
Chosen,fewStudies
CLB-Pt-CLB,clb-pt-clbProdrug
Traumatic,traumaticBreastNeuromas
Other,z-test
Cohort,peripheralBloodSamples
Contribution,analysisMayAid
Parameters,similarExperimentalParameters
Mastectomies,bilateralMastectomies
Description,greatPromise
Other,multigenePanels-with
Other,poorerPrognosis
Relapse,relapseRates
Other,theResulting
Other,groups
Other,NLR
Other,Disease
Other,recommendations
Benchmark,directTargetGene
Testing,age-basedScreeningPrograms
Food,assay
Protocols,treatmentProtocols
Strategy,nirFluorescenceImagingSystem
Other,megakaryocytes
Proportion,tumor-to-backgroundRatio
Alpha,sParticipants
Microfluidic,microfluidicChips
Nano-genosensor,nano-genosensor
Ecchymosis,enforcedExpression
Mood,2-groupRandomizedControlTrial
Biopsy,slnBiopsy
Purpose,use
Baseline,baselineSolubleSt-2Level
Treatments,non-standardPromptTreatments
Other,mechanisms
Other,recurrence-free-survival
Other,mostPatients
Other,overexpression
Other,stage
Other,proposedAlgorithm
Other,microRNAs
Other,manyFeatures
Discovery,improvedDetection
Trastuzumab,trastuzumab
Other,thepresence
Hazard,hazardRates
Other,Referrals
Ecchymosis,glut1Expression
Description,result
Aberrances,aberrances
Other,MicroRNAs
Other,BRCAs
Other,receptorActivator
Sprays,ddtSprays
Other,adjuvantEndocrineHormonalTherapy
Other,overallMediumSecondTumor-freeTime
Periods,longerPeriods
Other,archivedFormalin-fixedParaffin-embeddedTissue
16,mStage
Numerous,manyComputerVisionApplications
16,20
Other,determining
Other,Cases
Other,novelNavigationSurgery
Testing,breastScreening
Adult,commonAdultCancers
Learning,extremeLearningMachineClassification
Water,water
Other,DCR
Other,little
Other,respondents
Other,twoScales
Other,primaryTumours
Variants,single-nucleotideVariants
Distinct,differentLong-termSurvival
Other,usefulness
Aspiration,fine-needleAspirationCytology
Late-stage,late-stageCancerDiagnosis
Filter,osteopontin-basedProbe
Binding,denosumabInjection
Subtypes,biologicalSubtypes
Interference,intervention
Other,49Patients
Depletion,depletion
Other,remarkableImprovements
Other,decreases
Amplification,fxyd3Amplification
Other,conservativeTreatment
Other,emergingTechnology
Craniotomy,craniotomy
Other,0.84
Periods,periods
Resistance,theirApplication
MiRNAs,deregulatedMirnas
Numerous,manyPatients
Other,appropriateInterpretation
TAMs,TAMs
Other,-916
Actual,currentFollow-up
Other,We
Other,navigationSurgery
Axillary,axillarySurgery
Description,regressionModel
Discovery,breastCancerDetectionMethod
Ecchymosis,highGlut1Expression
Exposure,equivalentPerformance
Enhancer,enhancerRegions
Other,multimodalTherapy
Alpha,p<
Restoration,restoration
DNA,aberrantDnaMethylation
Other,biomarker
Other,complaint
Restoration,publicHealthCareSystem
Other,pi3k/aktSignaling
Danger,commonCause
Purpose,importantRole
Other,SUVmax
Presentations,presentations
Subtype,specificSubtype
Other,tomography
Focus,sentinelLymphNode
Annexin,annexinVStaining
Other,maintainedBreastCancerDatabase
Other,radiationTherapy
Conjugate,anti-ronMonoclonalAntibodyZt/g4-drugMonomethylAuristatinEConjugate
Entry,counseling
Testing,research
Nondestructive,nondestructiveTests
Intensity,value
Other,mortality
Other,12404Patients
Other,roles
160,160Patients
Other,interplay
MORC4,morc4Silencing
Monte,monteCarloFeatureFeatureMethod
Contribution,bestAvailableEvidence
Other,additionalAnalyses
Other,Depletion
Discovery,detectionMethod
Other,ORR
Hybrid,carrier
Other,progressionDisease
Spouse,spouse
Fibroblasts,cancerFibroblasts
Other,65Patients
NSAID,nsaidUsers
Ecchymosis,decreasedExpression
Authors,authors
Axillary,axillaryDissection
Other,treatmentStrategies
Levels,plasmaLevels
Other,pattern
Other,TRPV1
Radiotherapy,chemotherapyHormonalTreatment
Other,segmentationAlgorithm
Bromide,bromideAssay
Caregiver,case
Image,imageSegmentation
Somatic,esr1SomaticAlterations
Pathogenic,pathogenicVariants
Mechanism,mechanism
Biocharacter,biocharacter
Other,4248BreastCancerPatients
Considerable,matchedHealthyTissues
Hazard,surgicalOutcome
Platinum,twoChlorambucilPlatinum
Other,precision
Cell,cell
Entry,additionalInformation
Cox,multivariateCoxProportionalHazardRegressionAnalysis
Ecchymosis,nek6Expression
Differentials,differentials
Factors,3ClinicopathologicalFactors
Other,sustainedStableDisease
Other,myeloperoxidase
Conflict,strongContrast
Other,breastCancerPatients
Black,blackWomen
Other,physician
Other,Utilization
Texture,textureAnalysis
Other,Follow-up
Survival,overallMedianSurvival
Signatures,collectedSignatures
Demographics,Demographics
Testing,comparison
Other,survivalDistributions
Other,recurrence
Sensitive,sensitiveNano-genosensor
Other,status
Other,mammographicImages
Cox,coxHazardRegressionAnalysis
Quantification,successfulQuantification
Other,conventionalTreatmentProcesses
Other,methods
Comparisons,Comparisons
Craniotomy,excision
Focus,sentinelLymphNodeBiopsy
Focus,two-yearStudy
16,12SampledWomen
Water,essentialRole
Other,suchSymptoms
Symptom,evidence
SPD,proposedCovariance-basedSpdMatrices
Testing,screeningTools
Survival,three-yearSurvivalRates
Immunohistochemistry,ELISA
Restoration,development
Other,ruralCancerHospital
Contribution,coverageRates
Platform,platform
Hybrid,oneMutation
Other,effects
Aptamer,aptamerMf3
Purpose,hormonalContraceptionUse
Purpose,itsRole
Testing,histologicalExamination
Other,positiveTreatment
Other,australianSynchrotron
Other,cells
Other,ourFindings
Other,relapse
Intensity,highIndex
Mastectomies,mastectomies
Other,proteinKinase
Other,ongoingTrials
Other,gonadotropin
MiR-34s,miR-34s
Intensity,imageQuality
Radiotherapy,palliativeChemotherapy
Atypia,nuclearAtypia
Other,total
Other,481Women
Phenotype,textureFeatures
Other,areas
Focus,cross-sectionalStudy
Other,breastImagingModality
Strategy,strategy
Evolve,ageGroups
Testing,breastCancerScreening
Other,five
Scans,chestCtScans
Radiomics,radiomicsScore
Preterm,mostPretermBirth
Other,allBreastCancerPatients
Other,pH
Other,parpInhibitors
Signature,lifestyleModification
Other,Increase
Food,mtorInhibitorEverolimus
Other,collapsing
Zt/g4-MMAE,Zt/g4-MMAE
Propensity,propensityScoreMatchingAnalysis
Other,secondTumor
Seven,sevenWomen
Other,recognizingMethylationStatus
Post-NAC,post-NAC
Other,analyzing
Utilized,currentUtilizedHistopathologicBiomarkers
Postmenopausal,postmenopausalPatient
Parameters,morphologicParameters
Platinum,chlorambucilPlatinum
Other,mastectomiedPatients
Chinese,chineseExpertGroup
Bromide,-25-diphenyltetrazoliumBromideAssay
Radiotherapy,chemotherapyGroups
Signature,interval
Other,filipinoWomen
Troponins,troponins
Other,luminalB-likePatients
Of121,totalOf121Patients
Other,incidence
Testing,review
Hyperintense,irregularHyperintenseLesion
Other,lipidProfiles
Filter,ultrasound-guidedDiffuseOpticalTomography
VAP-1,vap-1StainingResults
DDTs,DDTs
Macrophages,macrophages
Kazakhstan,Kazakhstan
Allele,rs5743810ProAllele
Ecchymosis,itsExpression
Number,increasingNumber
Other,differentialDiagnoses
Targeted,targetedTherapies
Intensity,volume
Other,breastConservation
Testing,screening
Other,advances
Network,networkOutput
Other,non-coverage
Prevention,prevention
GTPase,GTPase
Protocols,protocols
Obesity,Obesity
Other,score
Testing,screeningBehavior
Other,prognosticStagingSystems
Other,biomarkers
Solicitations,solicitations
Signature,subtype-specificSignature
Other,sparseCoding
Other,hypothesis
Other,breastCancerRelapse
Susceptibility,barcodeMode
Other,controls
Other,experts
Other,Results
Multiplex,multiplexAssay
Other,preoperativeDiagnosis
TAAs,TAAs
Other,overview
Genes,genes
Conflict,dual-phaseContrast
Discovery,finding
Cytology,breastCancerGenetics
Other,mriImaging
Pearson,pearson'sR
Levels,post-nacBpeLevels
Reporter,dual-luciferaseReporterAssays
Other,portugueseInstitute
Other,coding
Antibody,antibodyPanel
Other,CTCs
Testing,ourTheoreticalAnalysis
Hazard,poorerOutcome
Supplements,promisingSupplements
Computer,Computer
Reduced,smallPopulation
Strategy,screeningStrategy
Description,model
Survival,medianProgression-freeSurvival
Other,Management
Cytology,invasiveLobularHistology
Multi-stimuli-responsive,multi-stimuli-responsiveTheranosticNanoplatform
Testing,examination
Other,characteristics
Subjective,subjectiveRisk
Atypia,atypia
Other,sequencing
Survival,breastSurvival
Access,Access
Other,bio-metal-organicFrameworkCoated
Other,knowledge
Entry,information
Other,Radiotherapy
Other,disease
Syndrome,syndrome
Almaty,almatyCity
Accumulation,data
Other,identified
Cox,coxModel
Output,paper
Other,ruralSetting
Cox,coxHazardRegressionModels
Treatments,selectedStandardTreatments
Intensity,prognosticValue
Issues,issues
Targeted,novelTargetedTherapeuticOptions
Analytics,dataAnalytics
Discovery,ca15-3Detection
Other,commonCancer
Contribution,aromataseInhibitor-inducedBoneLoss
Other,mainMeasures
Necessity,need
Other,alternativeOption
Intensity,highCorrelation
Other,SP
Considerable,significantHigherRisk
Focus,focus
Contribution,highCoverage
Other,management
JAK-STAT,jak-statPathway
Other,OP
Collision,impact
Provider,relatedTranscriptionFactorSox9
Other,ductalCarcinoma
Other,Factors
Treatments,treatments
Other,99Percecnt
Other,individuals
Values,optimalCutoffValues
Other,Biomarkers
Discovery,detection
16,1000Patients
Adulthood,years
CNVs,CNVs
Other,MethyLight
Purpose,ourAim
Other,staining
Description,treatmentOutcomePrediction
Autoantibodies,autoantibodies
Other,quantitativeRealTimeFluorescencePolymeraseChainReaction
Hybrid,pD1542yMissenseMutation
Other,alexnetModels
Discovery,earlyBreastCancerDetectionSystems
Purpose,diagnosticRole
Mood,breastCancerControl
10-year,breastCancer-specific10-yearSurvival
Other,improvedCancerTreatment
Testing,PM
Description,challenge
Proportion,ratio
Mood,controlTrial
Heterogeneity,heterogeneity
Numerous,numerousGene-expression-basedPrognosticSignatures
Hazard,highestRisk
Radiotherapy,neoadjuvantChemotherapy
Other,
Restoration,primaryCareProvider
Considerable,otherSignificantConcerns
Other,prognosis
Actual,actualIncidence
Testing,rnaSequenceAnalysis
Other,stageI/iiaCases
Other,aspects
Mutations,mutations
Entry,induction
Intensity,massProduction
Other,geometries
Other,diseases
Other,2921Posts
Other,Delays
AD,adPatients
Alpha,a
She,She
Activities,activities
Other,volumes
Other,antibody-anchoredMagneticBeads
Contribution,ccsCoverage
Benchmark,target
CircRNAs,circRNAs
Other,imagingIndexes
Other,hormone-dependentPositiveBreastCancer
Distinct,differentStudies
Other,obtainedFeatures
Conflict,dynamicContrast
Other,macrophage-targetedTreatmentStrategies
Decrease,increase
Other,clinicalCharacteristics
Other,method
Other,incidenceRates
Nonparticipation,resistance
Late-stage,late-stage
Conflict,contrast
16,11HereditaryBreastCancerGenes
Other,differentiation
Investigation,Investigation
Individuals,Individuals
Other,responsibleMechanisms
Hazard,clinico-pathologicalRiskFactors
SE,highestSe
Intensity,lowLevel
Other,greatProgress
Circulating,sixCirculatingMirnas
Other,84Patients
Collision,recurrentWords
Other,Patients
Other,intensive
Cytology,cytology
Other,clinicians
Other,clinicalRecords
Postmenopausal,952PercecntOfthePostmenopausalWomen
Other,CGI
Other,higher-qualityImaging
Other,42Patients
Conflict,activity
Other,Use
Other,majority
OS,betterOs
CEDM,CEDM
Other,133BreastCancerCases
Other,epidemiologicalFeatures
Focus,sentinelNodeBiopsy
Will,furtherUnderstanding
Other,Non-linearity
Other,convolutionalNeuralNetworks
Other,selectedPatients
Other,intracellularLevel
Contribution,mainContribution
Parameters,quantitativeParameters
Other,rareTumor
Testing,breastExamination
Other,features
Simulated,simulatedInnerBreastTissue
Other,Analysis
Other,eventualKnowledge
Women,conclusionsWomen
Other,olderWomen
Purpose,objectiveResponseRate
Hazard,summaryHazardRatios
Other,furtherStudies
Simulated,simulatedBreastCancer
Other,tumorUptake
Intrapulmonary,newBilateralIntrapulmonaryNodules
Aberrances,multipleGeneticAberrances
Caregiver,caseRecords
Purpose,objective
Necessity,necessity
Subset,subset
Other,experiences
Purpose,mainObjective
Other,severalPatients
Reporter,luciferaseReporterAssay
CNN,shallowCnn
Interference,newerDrugDeliveryStrategies
16,22Patients
Other,diagnosed
Description,higherResolution
Testing,fisherAnalysis
Alterations,esr1Alterations
Intensity,smallProportion
Specimen,specimen
Survival,survival
Description,mainChallenge
Other,accurateMethod
Users,12331Users
Nonparticipation,endocrineResistance
Obstetrician,obstetrician
Other,evaluation
Correlation,expectedInverseCorrelation
Other,otherDietaryRecommendations
Regimens,newTreatmentRegimens
Other,observationalStudies
Other,estrogenReceptor
Alpha,fluorescenceImagingExVivo
Other,main
Other,Therapies
Distinct,differentPrognosis
Food,goal
Aspiration,aspirationCytology
Apatinib,tolerabilitytheApatinib
Cytology,histology
Levels,ctnLevels
Other,alternativeMeans
Other,pathway
Other,1444Women
Other,outliers
Biopsy,biopsy
Adverse,similarSeriousAdverseEvents
Other,recentStudies
Decision-making,personalDecision-making
SNPs,SNPs
Platform,clearcellPlatform
Hazard,outcome
16,100000Person-years
Number,numberVariants
Other,patients'Prognosis
Testing,linerRegressionAnalysis
Testing,combinedAnalysis
Other,standard
Other,it
Sites,keyHypomethylationSites
Predominant,frequentMutations
Other,percecntConfidenceIntervals
Subgroup,association
Other,606Percecnt
Other,targetedTherapies
Conflict,availableContrastAgents
16,10Mg/kg
Description,characterization
Intensity,optimalCut-offValue
Other,splenicLymphocytes
Other,DAU
Focus,non-sentinelLymphNode
Axis,pdgfs/pdgfrsAxis
Values,theory
Other,causes
Nonparticipation,nippleInvolvement
Random-sampling,random-samplingMethod
Other,tools
Positivity,accuracy
Intensity,mass
Other,lobularCarcinoma
Other,nodalMegakaryocytes
Technique,novelPowerfulTechnique
Other,summary
Other,methylation
Testing,medicalStatus
FOXC1,FOXC1
Distance,firstTime
Other,trend
Testing,advancedAnalysis
Membrane,panel
Other,antibodies
Description,finalMultipleRegressionModel
Filter,similarTowaveletFilter
Correlation,correlation
Predominant,frequentCancer
Technique,technique
Other,localTherapy
Mutations,twentyUniqueEsr1Mutations
Other,history
Sites,hypomethylationSites
16,mPatients
Other,Anthracyclines
Hypomethylation,hypomethylation
Other,China
Other,findings
Other,localRecurrence
Other,treatment
Other,differentialDiagnosis
Steps,Steps
Users,12331Non-nsaidUsers
Young,female
Other,xenograftMice
Acids,omegaFattyAcids
Interference,postOperativeAssessment
OS,osAdvantage
Of121,of121Patients
Stigmatization,stigmatization
Interference,postAssessment
Other,found
Other,humanChorionicGonadotropin
Guidelines,guidelines
Radiotherapy,chemotherapyRecommendations
Other,statisticalClassifiers
Conflict,significantDifference
Advantage,handicap
Pearson,Pearson
Other,suutaneousLymphaticChannels
Considerable,significantAdvances
Nek6,Nek6
Other,transport
Other,suutaneousBreastTumor
Other,Screening
Nanoplatform,nanoplatform
Focus,axillaryLymphNode
Other,133Controls
Will,understanding
Regimens,treatmentRegimens
Subtypes,subtypes
Phenotype,phenotypeExpression
PFS,PFS
Mutations,uniqueEsr1Mutations
CTC,ctcCounts
Other,SD-CNN
Cytology,surfaceMorphology
Other,conventionalX-rayMammography
Mood,greaterthanorequalto10PercecntDecline
Intensity,highExpression
Alpha,r
Other,tanUsage
Other,cases
Other,clinicalOutcomesDiffer
9398,9398
Testing,scan
Description,prediction
Hazard,cancerRiskPerception
Other,concentrations
Testing,cytologicalExamination
Other,reality
Reduced,smallMoleculeInhibitors
Exposure,performance
Other,synthesisMethods
Cohort,blood
Caregiver,type
Description,clinicalPicture
Supplements,supplements
77,77Patients
Other,mostWomen
Urgent,urgentCytology
Other,51Patients
Other,therapeuticSequencing
Other,meanTime
Ecchymosis,inhibition
Other,limitedLiterature
Other,importance
Parameters,ivimParameters
Other,changes
NSAIDs,NSAIDs
Comparisons,comparisons10-yearSurvival
Craniotomy,surgicalExcision
Other,lymphocytes
Other,Identification
Cytology,intraoperativeScrapeCytology
Cell,capacitance
Considerable,largeBreastCancerTissueMicroarray
Other,westernBlotAnalyses
Other,psychologicalAspects
CNN,CNN